Latest Breaking News On - Pharmaceutical trading down - Page 1 : comparemela.com

TD Cowen Boosts Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $61.00

TD Cowen Boosts Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $61.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

JapanCanadaChinaUnited statesAmericaRobertw bairdThomas richard kassbergCantor fitzgeraldChina universal asset management coUltragenyx pharmaceutical incCanaccord genuity groupSecurities exchange commissionAssociates corpRoyal bankJpmorgan chase coCovestor ltd

Wedbush Reaffirms "Neutral" Rating for Ultragenyx Pharmaceutical (NASDAQ:RARE)

Wedbush Reaffirms "Neutral" Rating for Ultragenyx Pharmaceutical (NASDAQ:RARE)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesJapanMontrealQuebecCanadaAmericaRobertw bairdThomas richard kassbergUltragenyx pharmaceutical company profileUltragenyx pharmaceutical incDimensional fund advisorsCantor fitzgeraldCanaccord genuity groupMetlife investment managementRaymond james associatesJpmorgan chase co

Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Down 3.6%

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Free Report)’s stock price traded down 3.6% on Friday . The stock traded as low as $16.04 and last traded at $16.04. 603 shares traded hands during trading, a decline of 87% from the average session volume of 4,726 shares. The stock had previously closed at $16.64. Ono […]

Ono pharmaceutical company profileOno pharmaceutical co ltdGet free reportPharmaceutical trading downOpdivo intravenous infusionKyprolis intravenous injectionOno pharmaceutical dailyOno pharmaceuticalOtcmkts ophlfOphlfMedicalStocksTechnicals

Caprock Group LLC Decreases Stock Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Caprock Group LLC decreased its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 51.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,907 shares of the company’s stock after selling 34,369 shares during the period. Caprock Group […]

JapanLegacy wealth asset managementBlue trust incCaprock groupExchange commissionTakeda pharmaceutical company limitedBruceg allen investmentsSecurities exchange commissionRaymond james associatesTakeda pharmaceutical companyCo ltd takedaCitigroup incFree reportTakeda pharmaceuticalWealth asset managementPharmaceutical trading down

Values First Advisors Inc. Sells 9,642 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Values First Advisors Inc. trimmed its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 22.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,865 shares of the specialty pharmaceutical company’s stock after selling 9,642 shares during the period. […]

United statesMontrealQuebecCanadaAmericanScott dreyerPiper sandlerFirst advisors incCollegium pharmaceutical incFinancial services group incSecurities exchange commissionAmerican century companies incJefferies financial groupNeedham companyNasdaqEnvestnet asset management inc